Research led by Amsterdam UMC, across more than 5 years and 1100 patients has demonstrated a strategy for reducing inappropriate IV use by a third, an effect that was sustained across the five-year period.
MHRA strengthens regulations on fluoroquinolone antibiotics use
Share this article The MHRA’s new restrictions on fluoroquinolone antibiotics limit their use to ensure patient safety. Credit: fizkes / Shutterstock.com. The UK Medicines and
January 23, 2024